A closer look at “CMS Targets 340B Drug Discount Program Overhaul to Curb Hospital Subsidy Abuse”, exactly as the source publishes it. The 340B drug discount program, originally designed as a modest support for safety-net hospitals, has ballooned into a large institutional subsidy with costly unintended consequences, according to a senior official at the U.S. Department of Health and Human Services. The Centers for Medicare & Medicaid Services (CMS) is now planning a major fix to address what the agency describes as a fundamental flaw in the program’s structure.
The official argues that the program’s explosive growth has shifted benefits away from vulnerable patients and toward hospital systems that may not need the financial support. CMS is expected to propose new rules that could narrow eligibility or add transparency requirements to ensure discounts actually help low-income communities. This listing links straight to the original page, where the content is available in full.